Verrica Pharmaceuticals Inc. (VRCA) Operating income 2017–2025
Verrica Pharmaceuticals Inc. (VRCA) annual operating income history from SEC filings — each fiscal year as reported.
-$12.2MFY2025 · since FY2017: -$4.5M → -$12.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.2M | +81.5% |
| FY2024 | -$65.9M | -0.2% |
| FY2023 | -$65.8M | -208.8% |
| FY2022 | -$21.3M | +31.1% |
| FY2021 | -$30.9M | +23.1% |
| FY2020 | -$40.2M | -33.6% |
| FY2019 | -$30.1M | -37.5% |
| FY2018 | -$21.9M | -390.9% |
| FY2017 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating marginVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →